A. Florl

发表

Tumour class prediction and discovery by microarray-based DNA methylation analysis.

Fabian Model, Christian Piepenbrock, Péter Adorján, 2001, Nucleic acids research.

Tumour class prediction and discovery by microarray-based DNA methylation analysis

Thomas D. Otto, Peter Adorjan, Fabian Model, 2002 .

DNA methylation alterations in urothelial carcinoma

W. Schulz, M. Grimm, A. Florl, 2006, Cancer biology & therapy.

Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation

R Engers, W. Schulz, R. Ackermann, 2004, British Journal of Cancer.

E-cadherin involved in inactivation of WNT/β-catenin signalling in urothelial carcinoma and normal urothelial cells

W. Schulz, S. Swiatkowski, H. Seifert, 2003, British Journal of Cancer.

Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer

Thomas Lengauer, Masanori Yamanaka, Adrian Alexa, 2007, Molecular Cancer.

Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.

C. Suschek, W. Schulz, H. Geddert, 2006, European journal of cancer.

Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells

W. Schulz, A. Florl, Andrea R. Florl, 2003, Genes, chromosomes & cancer.

Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer

Hans-Helge Seifert, W. Schulz, H. Seifert, 2008, International journal of cancer.

Denaturing high‐performance liquid chromatography (DHPLC) as a reliable high‐throughput prescreening method for aberrant promoter methylation in cancer

W. Schulz, P. Dall, H. Seifert, 2004, Human mutation.

Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder

W. Schulz, M. Knowles, H. Seifert, 2001, British Journal of Cancer.

DNA Methylation and the Mechanisms of CDKN2A Inactivation in Transitional Cell Carcinoma of the Urinary Bladder

W. Schulz, C. Gerharz, H. Seifert, 2000, Laboratory Investigation.

Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines

T. Efferth, W. Schulz, V. Balz, 2005, Genes, chromosomes & cancer.

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines

R. Stoehr, W. Schulz, J. Hatina, 2012, Cellular Oncology.

Application of a modified real-time PCR technique for relative gene copy number quantification to the determination of the relationship between NKX3.1 loss and MYC gain in prostate cancer.

B. Wullich, V. Jung, W. Schulz, 2005, Clinical chemistry.

Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo‐1) gene promoter at rel/nuclear factor κB sites in prostatic carcinoma

W. Schulz, W. Müller, A. Florl, 2001, Molecular carcinogenesis.

Disruption of the FA/BRCA pathway in bladder cancer

M. Schmid, C. Steinlein, M. Schmid, 2007, Cytogenetic and Genome Research.

Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder.

W. Schulz, C. Steinhoff, H. Seifert, 2001, Mutation research.

Chromosomal instability in bladder cancer

W. Schulz, A. Florl, 2008, Archives of Toxicology.

Methylation of endogenous human retroelements in health and disease.

W. Schulz, C. Steinhoff, A. Florl, 2006, Current topics in microbiology and immunology.

DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas

R. Löwer, W. Schulz, B. Schmitz-Dräger, 1999, British Journal of Cancer.

Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma

W. Schulz, C. Gerharz, C. Mahotka, 2003, International journal of cancer.

Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer

W. Schulz, A. Otte, M. Hoffmann, 2007, Cancer biology & therapy.

High frequency of alterations in DNA methylation in adenocarcinoma of the prostate

W. Schulz, R. Ackermann, A. Florl, 1999, The Prostate.

DNA methylation in placentas of interspecies mouse hybrids.

W. Schulz, M. Hemberger, W. Shi, 2003, Genetics.

Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not in esophageal and cardiac adenocarcinoma

H. Geddert, H. Gabbert, M. Sarbia, 2004, International journal of cancer.

Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage.

B. Wullich, W. Schulz, J. Lehmann, 2006, European urology.

Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cells.

W. Schulz, S. Krause, A. Florl, 2008, Mutation research.

In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer.

W. Schulz, R. Ackermann, H. Seifert, 2005, Experimental and molecular pathology.

Hypomethylation of the XIST gene promoter in prostate cancer.

Wolfgang A. Schulz, W. Schulz, R. Engers, 2005, Oncology research.

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines

R. Stoehr, W. Schulz, J. Hatina, 2012, Cellular Oncology.

Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma

T. Visakorpi, W. Schulz, H. Seifert, 2002, Genes, chromosomes & cancer.

Novel mutations of the von Hippel‐Lindau tumor‐suppressor gene and rare DNA hypermethylation in renal‐cell carcinoma cell lines of the clear‐cell type

P. Wernet, W. Schulz, C. Gerharz, 2000, International journal of cancer.

Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer

B. Wullich, Adrian Alexa, M. Hoffmann, 2007 .

Multiple mechanisms downregulate CDKN1C in human bladder cancer

W. Schulz, H. Seifert, M. Hoffmann, 2005, International journal of cancer.